Withdrawal of Registration Statement (rw)
28 Fevereiro 2023 - 4:20PM
Edgar (US Regulatory)
VIVEON HEALTH ACQUISITION
CORP.
c/o Gibson, Deal & Fletcher, PC
Spalding Exchange
3953 Holcomb Bridge Road, Suite 200
Norcross, GA 30092
February 28, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: | Daniel
Crawford |
| Christine Westbrook |
Re: | Viveon
Health Acquisition Corp. |
| Registration
Statement on Form S-4
File No. 333-266123 |
| |
Ladies
and Gentlemen:
Viveon Health Acquisition Corp. (the "Registrant"), previously filed the above-referenced registration statement on Form S-4
(the "Registration Statement"), with related amendments, which was declared effective on November 14, 2022. Pursuant to Rule
477, promulgated under the Securities Act of 1933, as amended (the "Securities Act"), the Registrant hereby requests that the
Registration Statement, together with all amendments and exhibits, be withdrawn at your earliest convenience.
The Registration Statement was filed in connection with a proposed business combination pursuant to an Agreement and Plan of Merger,
by and among the Registrant, VHAC Merger Sub, Inc., and Suneva Medical, Inc., dated January 12, 2022 (the “Merger Agreement”).
On February 2, 2023, the Merger Agreement was terminated. As a result, the securities to be issued under the Registration Statement will
not be issued. The Registrant represents that no securities have been sold pursuant to the Registration Statement. The Registrant believes
withdrawal of the Registration Statement to be consistent with the public interest and the protection of investors.
The Registrant requests, in accordance with Rule 457(p) under the Securities Act, that all fees paid to the Commission in connection
with the filing of the Registration Statement be credited to the Registrant's account to be offset against any future filing fees.
If
you have any questions about this withdrawal request, please contact Tahra Wright at (212) 407-4122.
Sincerely,
Viveon Health Acquisition Corp.
/s/ Jagi Gill
Jagi Gill
Chief Executive Officer
Viveon Health Acquisition (AMEX:VHAQ)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Viveon Health Acquisition (AMEX:VHAQ)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024